Rekah Pharmaceutical Industry Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was ILS 72.46 million compared to ILS 64.68 million a year ago. Net income was ILS 0.539 million compared to ILS 1.89 million a year ago. Basic earnings per share from continuing operations was ILS 0.05 compared to ILS 0.16 a year ago. Diluted earnings per share from continuing operations was ILS 0.05.